Hidradenitis suppurativa

被引:3
作者
Gonzalez-Lopez, Marcos A. [1 ,2 ,3 ,4 ]
机构
[1] Hosp Univ Marques de Valdecilla, Serv Dermatol, Santander, Cantabria, Spain
[2] Univ Cantabria, Dept Med & Psiquiatria, Santander, Cantabria, Spain
[3] Inst Invest Marques de Valdecilla IDIVAL, Santander, Cantabria, Spain
[4] Real Acad Med Cantabria, Santander, Cantabria, Spain
来源
MEDICINA CLINICA | 2024年 / 162卷 / 04期
关键词
Hidradenitis suppurativa; Acne inversa; Immune-mediated diseases; Chronic inflammation; Comorbidities; SEVERITY ASSESSMENT; SCORING SYSTEM; DIAGNOSIS;
D O I
10.1016/j.medcli.2023.09.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hidradenitis suppurativa (HS) is a chronic and debilitating inflammatory disease derived from the pilosebaceous unit, that affects approximately 1% of the general population. Clinically, it is characterized by inflammatory nodules, abscesses, and tunnels in the intertriginous areas of the body, especially in the axillary, inguinal, and anogenital regions. The etiopathogenesis of HS is not completely understood, although it is considered to be multifactorial, and the result of a complex interaction between genetic, hormonal, environmental, and immunological factors. In this sense, several proinflammatory cytokines, such as tumor necrosis factor -alpha (TNF-a), interleukin (IL) -L -1p, and IL -17, among others, appear to play a crucial role in the pathogenesis of the disease. Currently, HS is recognized as a systemic disease associated with numerous comorbidities, including cardiovascular, immune -mediated, and endocrinemetabolic diseases. The treatment of HS must be carried out with an individualized and patient -oriented approach, considering medical and surgical treatment modalities. (c) 2023 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:182 / 189
页数:8
相关论文
共 60 条
[1]   The Role of Hormones in Hidradenitis Suppurativa: A Systematic Review [J].
Abu Rached, Nessr ;
Gambichler, Thilo ;
Dietrich, Johannes W. ;
Ocker, Lennart ;
Seifert, Caroline ;
Stockfleth, Eggert ;
Bechara, Falk G. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
[2]   North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations Part II: Topical, intralesional, and systemic medical management [J].
Alikhan, Ali ;
Sayed, Christopher ;
Alavi, Afsaneh ;
Alhusayen, Raed ;
Brassard, Alain ;
Burkhart, Craig ;
Crowell, Karen ;
Eisen, Daniel B. ;
Gottlieb, Alice B. ;
Hamzavi, Iltefat ;
Hazen, Paul G. ;
Jaleel, Tara ;
Kimball, Alexa B. ;
Kirby, Joslyn ;
Lowes, Michelle A. ;
Micheletti, Robert ;
Miller, Angela ;
Naik, Haley B. ;
Orgill, Dennis ;
Poulin, Yves .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (01) :91-101
[3]   Bacterial biofilm is associated with higher levels of regulatory T cells in unaffected hidradenitis suppurativa skin [J].
Andersen, Rune Kjaersgaard ;
Ring, Hans Christian ;
Kallenbach, Klaus ;
Eriksen, Jens O. ;
Jemec, Gregor B. E. .
EXPERIMENTAL DERMATOLOGY, 2019, 28 (03) :312-316
[4]   Identification of Three Hidradenitis Suppurativa Phenotypes: Latent Class Analysis of a Cross-Sectional Study [J].
Canoui-Poitrine, Florence ;
Le Thuaut, Aurelie ;
Revuz, Jean E. ;
Viallette, Cedric ;
Gabison, Germaine ;
Poli, Florence ;
Pouget, Florence ;
Wolkenstein, Pierre ;
Bastuji-Garin, Sylvie .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (06) :1506-1511
[5]   Intralesional Treatments in Hidradenitis Suppurativa: A Systematic Review [J].
Cuenca-Barrales, Carlos ;
Montero-Vilchez, Trinidad ;
Sanchez-Diaz, Manuel ;
Martinez-Lopez, Antonio ;
Rodriguez-Pozo, Juan Angel ;
Diaz-Calvillo, Pablo ;
Arias-Santiago, Salvador ;
Molina-Leyva, Alejandro .
DERMATOLOGY, 2022, 238 (06) :1084-1091
[6]   Topical 15% Resorcinol Is Associated with High Treatment Satisfaction in Patients with Mild to Moderate Hidradenitis Suppurativa [J].
Docampo-Simon, Alexandre ;
Beltra-Pico, Ivan ;
Jose Sanchez-Pujol, Maria ;
Fuster-Ruiz-de-Apodaca, Rosa ;
Selva-Otaolaurruchi, Juan ;
Betlloch, Isabel ;
Carlos Pascual, Jose .
DERMATOLOGY, 2022, 238 (01) :82-85
[7]   Risk of Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Hidradenitis Suppurativa [J].
Egeberg, Alexander ;
Gislason, Gunnar. H. ;
Hansen, Peter R. .
JAMA DERMATOLOGY, 2016, 152 (04) :429-434
[8]  
Garcia-Martinez F J, 2017, Semergen, V43, P34, DOI 10.1016/j.semerg.2015.12.005
[9]   A Practical Guide for Primary Care Providers on Timely Diagnosis and Comprehensive Care Strategies for Hidradenitis Suppurativa [J].
Garg, Amit ;
Naik, Haley B. ;
Kirby, Joslyn S. .
AMERICAN JOURNAL OF MEDICINE, 2023, 136 (01) :42-53
[10]   Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations [J].
Garg, Amit ;
Malviya, Neeta ;
Strunk, Andrew ;
Wright, Shari ;
Alavi, Afsaneh ;
Alhusayen, Raed ;
Alikhan, Ali ;
Daveluy, Steven D. ;
Delorme, Isabelle ;
Goldfarb, Noah ;
Gulliver, Wayne ;
Hamzavi, Iltefat ;
Jaleel, Tarannum ;
Kimball, Alexa B. ;
Kirby, Joslyn S. ;
Kirchhof, Mark G. ;
Lester, Janice ;
Lev-Tov, Hadar ;
Lowes, Michelle A. ;
Micheletti, Robert ;
Orenstein, Lauren A. ;
Piguet, Vincent ;
Sayed, Christopher ;
Tan, Jerry ;
Naik, Haley B. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (05) :1092-1101